Argentus Capital Management’s GSK GSK Stock Holding History

Argentus Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,258	Closed	-$68K	–	182
2016 Q3	$68K	Buy	1,258 +488	+63%	+$26.8K	0.02%	404
2016 Q2	$42K	Sell	770 -208	-21%	-$11K	0.02%	455
2016 Q1	$50K	Sell	978 -75	-7%	-$3.73K	0.02%	440
2015 Q4	$53K	Sell	1,053 -4,345	-80%	-$221K	0.02%	393
2015 Q3	$259K	Sell	5,398 -2,605	-33%	-$136K	0.04%	358
2015 Q2	$417K	Sell	8,003 -240	-3%	-$13.5K	0.06%	270
2015 Q1	$476K	Hold	8,243	–	–	0.08%	255
2014 Q4	$440K	Buy	+8,243	New	+$461K	0.07%	258

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argentus Capital Management's GSK Position: Q4 2016 in Review

Argentus Capital Management sold out of GSK (GSK) in Q4 2016, closing a stake of 1,258 shares — an estimated $68K sold.

Argentus Capital Management first reported a position in GSK in Q4 2014 and held it in 8 quarters. The position peaked at $476K in Q1 2015. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Argentus Capital Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Argentus Capital Management sold 1,258 GSK shares in Q4 2016, an estimated $68K.
Argentus Capital Management first reported a position in GSK in Q4 2014 and held it in 8 quarters.
Argentus Capital Management's GSK position peaked at $476K in Q1 2015.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.